Barely Significant
← all excerpts

Real-world analysis of teclistamab in 123 RRMM patients from Germany.

Leukemia · 2024 · PMC10844072 · PMID 38245601

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

showed a trendp = 0.07so close (0.05 < p ≤ 0.1)
Of note, PFS of patients treated with ide-cel showed a trend towards inferior outcomes in the multivariable analysis, albeit the limited case numbers ( p = 0.07, n = 21).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.